eVisit vs Candid Health: Revenue, Funding & Team Size Compared
eVisit generates $13.8M in revenue; Candid Health generates $13.5M. eVisit and Candid Health are close to the same size by revenue. The table below compares eVisit and Candid Health on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company | ||
|---|---|---|
| Revenue | $13.8M | $13.5M |
| Valuation | $110.5M | Not disclosed |
| Funding raised | $70.8M | Not disclosed |
| Team size | 99 | 94 |
| Founded | 2013 | 2019 |
| HQ | Mesa, United States | San Francisco, United States |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
eVisit at a glance
eVisit generates $13.8M in revenue with 99 employees, headquartered in Mesa, United States.
- Revenue
- $13.8M
- Valuation
- $110.5M
- Funding
- $70.8M
- Team size
- 99
- Founded
- 2013
eVisit’s leading virtual care platform enables healthcare organizations to improve outcomes, revenue, and efficiencies, using their own network of providers to deliver virtual care.
Candid Health at a glance
Candid Health generates $13.5M in revenue with 94 employees, headquartered in San Francisco, United States.
- Revenue
- $13.5M
- Team size
- 94
- Founded
- 2019
The revenue cycle automation platform.
Other eVisit alternatives
eVisit competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
eVisit vs Candid Health: frequently asked questions
Is eVisit or Candid Health bigger?
eVisit is the bigger company by revenue, at $13.8M against $13.5M for Candid Health.
How much revenue does eVisit make?
eVisit generates $13.8M in annual revenue with a team of 99.
How much revenue does Candid Health make?
Candid Health generates $13.5M in annual revenue with a team of 94.
How much funding has eVisit raised?
eVisit has raised $70.8M in total funding since it was founded in 2013.